The Rockley Group and Content Rules Ink Deal to Extend Gl... ( TORONTO May 16 2013 iReach/ -- ...)

The Rockley Group and Content Rules Ink Deal to Extend Global Reach

Date:5/16/2013

TORONTO, May 16, 2013 /PRNewswire-iReach/ -- The Rockley Group Inc., the world's most sought-after content strategy consultancy, announced today the licensing of The Rockley Strategic Method™ to Content Rules Inc., global content strategy and development experts.

(Photo: http://photos.prnewswire.com/prnh/20130516/CG15133)

The Rockley Strategic Method enables organizations to design adaptive structured content to reach customers anytime, anywhere, and on any device. Used by the world's leading brands, the method:

Identifies customer requirements
Defines structured content models for adaptive and responsive content
Determines how content will be reused and repurposed across media and devices and how it will adapt to changing customer needs
Identifies the tags (metadata) for retrieval and dynamic delivery
Determines how content should be managed throughout the entire content lifecycle
Defines the governance policies to manage the content from creation to retirement
Recommends appropriate tools and technology
Helps organizations to adapt to change

The Rockley Group has honed The Rockley Strategic Method for more than a decade; helping a broad range of organizations — from small, privately-owned firms to multinational Fortune 100 companies in the Life Sciences, Financial and High Technology industries — create, manage, and deliver content efficiently and effectively.

"We have worked closely with Content Rules management and staff on content strategy projects and have certified their team in our methodology," said Ann Rockley , Founder and President of The Rockley Group and the designer of T
'/>"/>

SOURCE The Rockley Group
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Apexus Answers Offers New Service: Live Scheduled 340B Group Chat
2. The MED Group Announces New Agreement with CareCentrix Effective May 1, 2013
3. ASSA ABLOY Door Group Announces RF Shielding Openings
4. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
5. Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients
6. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
7. Dr. William McGuire, Former UnitedHealth Group CEO, Joins Rebiotix Inc. Board of Directors
8. Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China
9. Industry Group To Vow That Boston Terror Attack Victims "Will Walk And Run Again"
10. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
11. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013

Post Your Comments:

(Date:7/25/2014)... Maine, July 25, 2014 IDEXX Laboratories, Inc. (NASDAQ: ... the second quarter of 2014 increased 11% versus the ... 1 for the second quarter of 2014 versus ... for changes in distributor inventory 2 . Earnings per ... 2014 increased 11% from the prior year period to ...

(Date:7/25/2014)... Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... reported financial results for the second quarter and ... "The second quarter of 2014 continued to ... , M.D., chief executive officer of Semler. "We ...

(Date:7/25/2014)... CHICAGO, Ill., July 25, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... ended June 30, 2014. "This was another ... earnings per share above our original guidance and announced plans ...

[0] IDEXX Laboratories Announces Second Quarter Results [0] Semler Reports Second Quarter 2014 Financial Results [0] AbbVie Reports Second-Quarter 2014 Financial Results

... ARBOR, Mich., Sept. 17 Terumo Heart, ... European Launch Symposium at the European,Association of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ) (Logo: ... of the European Clinical Trial results for ...

... to enter Phase 2 clinical development, PRINCETON, ... an innovator in the discovery and development of ... a Phase 2a,clinical study of PS433540, the company,s ... and endothelin receptor antagonist,(DARA) that is being developed ...

Cached Medicine Technology:Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results 2 Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 2 Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 3 Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 4 Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 5

Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)

(Date:7/26/2014)... Seattle, Wa (PRWEB) July 26, 2014 ... book review recently updated by Vkool.com, this ... natural and safe methods for treating all ... including:, Tinnitus due ... subjective tinnitus , Nerve pathway tinnitus ...

(Date:7/26/2014)... July 26, 2014 The U.S. Food & ... that includes a new medication guide for AndroGel to include ... side-effect of taking the topical low testosterone medication, notes Wright ... Inc., the makers of the low testosterone theapy drug, has ... pain, swelling or redness as signs of a blood clot ...

(Date:7/26/2014)... Wa (PRWEB) July 26, 2014 According ... updated by Vkool.com, this is a comprehensive guide that ... unwanted tattoos . This book also teaches them ... imitate common medical procedures in their own home for ... that "Get Rid Tattoo Naturally" book includes step-by-step tutorials ...

(Date:7/25/2014)... 2014 2014 Deep Research ... Chromatography Industry” is a professional and in-depth ... Gel Permeation Chromatography market. The report provides ... Permeation Chromatography definition, classification, application, and industry ... This research covers the international market analysis, ...

(Date:7/25/2014)... York (PRWEB) July 25, 2014 A ... summary judgment in two DePuy Pinnacle hip lawsuits ( ... way for the claims to go before a jury ... an opinion rendered on July 18th, U.S. District Judge ... that the two Plaintiffs’ claims may proceed to trial ...

Breaking Medicine News(10 mins):Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2 Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2 Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3 Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4 Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5 Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2 Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3 Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2 Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3 Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2 Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3 Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4

[0] Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com [0] FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward [0] "Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com [0] 2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com [0] First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports

... of researchers led by A. K. Rajasekaran, PhD, Director of ... a key protein involved in cell function and regulation is ... work is published online in the American Journal of ... Cigarette smoke is well recognized as a cause of lung ...

... SEATTLE March 21, 2012: Anxiety, depression, stress ... drug use in youth, according to a study from ... researchers from the University of Washington and Seattle University. ... eighth grade who felt more emotional support from teachers ...

... 2012) Ching-Hon Pui, M.D., a renowned leader in the ... the 2012 Pediatric Oncology Award from the American Society of ... better understanding the blood cancer,s biology and treatment as well ... will receive the award in June at the 2012 ASCO ...

... challenges reading in Arabic than native Hebrew or English speakers ... the brain divide the labor differently when the brain processes ... the result of a new study conducted by two University ... Safra Brain Research Center for the Study of Learning Disabilities ...

... Non-small cell lung cancer (NSCLC), the most common form ... chemotherapy. However, a small group of patients can also ... New research published in BioMed Central,s open access journal ... epidermal growth factor receptor (EGFR) using RNAi, alongside TKI ...

... , TUESDAY, March 20 (HealthDay News) ... from the left and right arms might help predict ... new study suggests. Researchers found that people with ... each arm are at higher risk of cardiovascular death ...

Cached Medicine News:Health News:Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke 2 Health News:Middle school teacher support lowers risk for early alcohol use 2 Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 2 Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 3 Health News:Brain's involvement in processing depends on language's graphic symbols 2 Health News:Brain's involvement in processing depends on language's graphic symbols 3 Health News:Double whammy: RNAi enhances lung cancer therapy 2 Health News:Blood Pressure Variance Between Arms Points to Heart Risk 2

Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke Middle school teacher support lowers risk for early alcohol use ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment Brain's involvement in processing depends on language's graphic symbols Double whammy: RNAi enhances lung cancer therapy Blood Pressure Variance Between Arms Points to Heart Risk

ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....

For the quantitative colorimetric determination of AST (SGOT) in serum....

For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....

... The stainer TST 44 is an ... needed in histology and cytology laboratories. It ... short time. Its again increased large number ... continuous working principle provides a high throughput. ...

Medicine Products:

ASAT (GOT) FS (IFCC mod.)AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)AST-GOT Slide Stainer